Hypertension Detection and Follow-Up Program (HDFP)
Note that you will be prompted to log in or register an account
Open BioLINCC Study See bottom of this webpage for request information
Dataset(s) Last Updated
January 3, 2018
Clinical Trial URLs
Primary Publication URLs
Commercial Use Data Restrictions No
Data Restrictions Based On Area Of Research No
This program was designed to test the efficacy of antihypertensive therapy in reducing all-cause mortality in a population-based study.
Several studies have indentified elevated arterial blood pressure as a prominent risk factor for morbidity and mortality from all causes in general, and cardiovascular disease in particular. However, they were not designed to determine whether reduction of blood pressure was accompanied by reduction of disease and death.
A population-based screening in 14 communities recruited 10,940 hypertensive participants, aged 30-69. They were randomly assigned to Stepped Care or Referred Care groups within each center by entry diastolic blood pressure.
The systematic effective management of hypertension has a great potential for reducing mortality for the large numbers of people with high BP in the population, including those with mild hypertension (JAMA 1979; 242:2562-2571).
Please note that researchers must be registered on this site to submit a request, and you will be prompted to log in. If you are not registered on this site, you can do so via the Request button. Registration is quick, easy and free.
Resources AvailableStudy Datasets Only
- There is no Data Dictionary associated with this study.
Persons using assistive technology may not be able to fully access information in the study documents. For assistance, Contact BioLINCC and include the web address and/or publication title in your message. If you need help accessing information in different file formats such as PDF, XLS, DOC, see Instructions for Downloading Viewers and Players.